
|Articles|March 1, 2002
Genetic test may predict disease progression, development
Alameda, CA-Early indications are that the Ocugene glaucoma genetic test (InSite Vision, Alameda, CA) has the potential of becoming a useful tool in determining the likelihood of glaucoma development or progression in certain patients.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retina Society 2026: MCO-010 optogenetic therapy maintains visual acuity gains through 4 years in advanced RP
2
Manju Subramanian, MD: anti-VEGF linked to kidney function decline
3
Retina Society 2026: Medium-dose OCU410 gene therapy cuts geographic atrophy progression by up to 32% in phase 2 trial
4
Retina Society 2026: Could statins reduce PVR risk after RD repair?
5












